Tagged With Pharmaceutical

Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use


Young people are experiencing rare cases of heart inflammation after getting coronavirus vaccines, but doctors say the risk of COVID-19 is far greater


3 lingering questions about COVID-19 vaccines will shape the pandemic's trajectory into 2022 and beyond



Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK


Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot


The US just authorized Pfizer-BioNTech's coronavirus vaccine for teenagers, making it the first COVID-19 shot OK'd for 12- to 15-year-olds



Precipio extends 2-day gain to 404% following launch of the company's COVID-19 test on Amazon


Healthcare CEOs on how the pandemic is shaping the future of work


Getting AstraZeneca's shot is safer than flying on a plane, experts say - the bigger problem is an 'explosion of vaccine skepticism'


Pfizer's COVID-19 shot remains highly protective against the coronavirus, longer-term data shows


Vaccinex stock soars 223% on partnership deals using its antibody discovery platform


J&J just asked the US for emergency authorization of its COVID-19 vaccine, kicking off a process that could green-light its shot within weeks



J&J's single-dose coronavirus vaccine is 66% effective against COVID-19, raising worries that some variants may lower protection


Johnson & Johnson's CEO says crucial coronavirus vaccine data will come by early next week


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results


Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.



Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorise the shot


The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot


Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic


French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline